Intervention: Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
Found 31 matching trials
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis
PHASE3
This randomized, double-blind, parallel group study compares the efficacy a...
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
N/A
The current study will assess the real - life effectiveness of adalimumab i...
Status
Completed
Location
Rheumatology Clinic /ID# 54768
Start Date
2011-06-29
Trial ID
NCT01387802
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
PHASE3
This open-label study will evaluate the efficacy and safety of tocilizumab ...
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)
N/A
The purpose of this study is to compare the incidence rates of infection am...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT01088321
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)
PHASE3
This 3 arm randomized open label study will evaluate the safety, tolerabili...
Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
N/A
This observational study will evaluate the safety, tolerability and efficac...
A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants
PHASE3
This open-label, single arm, Phase 3b study will evaluate the efficacy of t...
Status
Completed
Location
Uni Degli Studi Di L Aquila; Cattedra Di Reumatologia - Dept. Di Medicina Interna E San